Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient면역 저하 환자에서 SARS-CoV-2의 장기간 바이러스 배출Case Reports Published on 2021-02-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 치료제, [키워드] Administered Bendamustine CD4 Cell mediated immunity chain Chain Reaction Chemotherapy clinician COVID-19 COVID-19 case Day discharged Follicular lymphoma Immunocompromised patient immunocompromised state immunocompromised status less malignant lymphoma nasopharyngeal specimen Negative PCR onset of symptom patients PCR performed polymerase chain reaction positive Prolonged prolonged viral shedding reaction remained Replication SARS-CoV-2 SARS-CoV-2 PCR symptoms of COVID-19 T cell Treatment Viral viral replication viral shedding virus isolation [DOI] 10.1016/j.jiac.2020.12.001 PMC 바로가기 [Article Type] Case Reports
COVID 19 and liver: An A-Z literature reviewCOVID 19와 간: A-Z 문헌 검토Review Published on 2021-02-012022-09-11 Journal: Digestive and liver disease : official journal of [Category] SARS, 치료제, [키워드] advanced liver disease changed Clinical course coronavirus COVID -19 COVID 19 COVID-19 COVID-19 infected patient COVID-19 infection Critical derangement disease disease course drug Drug hepatotoxicity Effect hepatic injury Hepatocellular carcinoma hepatotoxicity Immunocompromised patient Immunocompromised patients Inflammatory response Intensive Laboratory literature review liver Liver damage Liver disease Liver function Liver injury liver pathology Liver pathology. liver transplant management marker occur outcome pandemic parameter pathological findings pathology pathophysiology patients Perspective prognostic effect proportion provide recommendations severe or critical illness Surveillance Temporal Therapeutic approach therapy Variation Viral viral infection [DOI] 10.1016/j.dld.2020.09.010 PMC 바로가기 [Article Type] Review
COVID-19 vaccination in immunocompromised patients면역저하 환자의 코로나19 예방접종Article Published on 2021-02-012022-09-11 Journal: Clinical Rheumatology [Category] 임상, [키워드] COVID-19 vaccination Immunocompromised patient [DOI] 10.1007/s10067-020-05547-w PMC 바로가기 [Article Type] Article
Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology departmentShort communication Published on 2021-01-292022-10-30 Journal: Journal of Translational Autoimmunity [Category] COVID-19, [키워드] antibodies antibody formation auto-immune disease B-cell Care clinical cohort of patient collected data common conducted Course COVID-19 COVID-19 infection COVID-19 positive patient detectable disease disease course hospital hyperinflammatory state Immunocompromised immunocompromised individuals Immunocompromised patient Immunocompromised patients immunodeficiency immunodeficient patients Immunologic deficiency syndromes immunology Immunosuppressive agents immunosuppressive drug immunosuppressive drugs incidence of COVID-19 indicate knowledge nasal swab Netherlands observation outpatient clinic pandemic Patient PCR positive PROTECT recommendation Research Result SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody severe disease course shown the disease therapy variable were measured with COVID-19 [DOI] 10.1016/j.jtauto.2021.100084 PMC 바로가기 [Article Type] Short communication
COVID-19 Antibodies and Outcomes among Outpatient Maintenance Hemodialysis Patients외래 유지 혈액 투석 환자의 COVID-19 항체 및 결과Article Published on 2020-12-092022-09-11 Journal: Kidney360 [Category] SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody Aside Asymptomatic asymptomatic infection Black race Clustering COPD coronavirus COVID-19 COVID-19 antibody COVID-19 infection dialysis End stage renal disease Hemodialysis Hispanic ethnicity hospital hospital mortality rate Hospitalization Hospitalized Immunocompromised Immunocompromised patient Immunocompromised patients implication Infection maintenance Maintenance hemodialysis Mortality mortality rates nasopharyngeal New York occur other variable Outpatient outpatients Patient patients PCR positive PCR positivity positive PCR result Prevalence prevalent public health renal renal disease respiratory reverse-transcriptase PCR risk factor RT-PCR SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 positivity Seroconversion serologic testing seropositive Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus significant difference significant differences significantly taxis tested the patient [DOI] 10.34067/KID.0006292020 PMC 바로가기 [Article Type] Article
COVID‐19 in a child with primary antibody deficiencyCase Report Published on 2020-12-082022-11-01 Journal: Clinical Case Reports [Category] COVID-19, [키워드] COVID‐19 COVID‐19 deficiency Diagnosis early diagnosis exacerbating Immunocompromised patient immunodeficiency infected patients Mild Patient PID primary antibody primary antibody deficiency Primary Immunodeficiency SARS‐COV2 Severe infection Symptom Symptoms Treatment [DOI] 10.1002/ccr3.3643 PMC 바로가기 [Article Type] Case Report
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnologyReview Published on 2020-12-022022-10-04 Journal: International immunopharmacology [Category] MERS, SARS, 유전자 메커니즘, [키워드] ACE acute respiratory syndrome administration affecting albumin Alter assist association Cancer cancer patient Cancer patients caused condition contribute coronavirus Coronavirus disease 2019 COVID COVID-19 COVID-19 vaccine distribution effective effective vaccine Effective vaccines Efficacy exacerbated faster global pandemic highlighting immune system Immunocompromised immunocompromised individuals Immunocompromised patient implementation Interaction lack limitation Lipid nanoparticles mechanism mortality rate mRNA vaccine Nanomaterial Nanotechnology Neutrophils pandemic Patient personalised Pharmaceutics Prevalence required SARS-CoV-2 show the vaccine Treatment Vaccine Vaccine development vaccine platform viral spike protein viral strains Viral vector virus [DOI] 10.1016/j.intimp.2020.107247 PMC 바로가기 [Article Type] Review
The duration of infectiousness of individuals infected with SARS-CoV-2SARS-CoV-2에 감염된 개인의 감염 기간Review Published on 2020-12-012022-09-11 Journal: The Journal of Infection [Category] SARS, 치료기술, [키워드] CENTRAL close contact Contact tracing coronavirus COVID-19 COVID-19 patient Critical Culture Europe Evidence evidence of greater Immunocompromised Immunocompromised patient Immunocompromised patients index case indicate individual infected with SARS-CoV-2 Infectious virus infectiousness Isolation laboratory-confirmed Mild-to-moderate no evidence of occurred onward transmission Patient patients PubMed Central review Ribonucleic acid RNA SARS-CoV-2 symptom onset Symptoms unlikely virus virus culture [DOI] 10.1016/j.jinf.2020.10.009 PMC 바로가기 [Article Type] Review
Recurrent Positivity of SARS-CoV-2 RNA in a Clinically Recovered COVID-19 Patient with End-stage Renal Disease: A Case ReportCase Report Published on 2020-11-302022-10-30 Journal: JNMA: Journal of the Nepal Medical Association [Category] COVID-19, SARS, [키워드] coronavirus disease end-stage kidney disease severe acute respiratory syndrome coronavirus-2 acute respiratory syndrome characterized clinical implication clinically coronavirus disease Coronavirus-2 COVID-19 disease End-stage renal disease immune dysfunction Immunocompromised patient increase Infectious disease Live virus Mild onset of symptom Patient patients Pneumonia positive recovered Recurrent renal report reported risk RNA SARS-CoV-2 RNA Severe case uremia [DOI] 10.31729/jnma.5249 PMC 바로가기 [Article Type] Case Report
Case Report: A Patient with COVID-19 under Myelosuppression Induced by ChemotherapyArticles Published on 2020-11-162022-10-28 Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, SARS, [키워드] Chemotherapy COVID-19 Deterioration died Fever immune Immunocompromised patient immunodeficient patient induced information lymphoma mantle cell mild symptoms Negative PCR proceed SARS-CoV-2 Spread thought treated with COVID-19 [DOI] 10.4269/ajtmh.20-0678 PMC 바로가기 [Article Type] Articles